Masao Fukunaga Selected Research

Masao Fukunaga Research Topics

Disease

36	Osteoporosis 01/2023 - 11/2003
7	Bone Resorption 11/2013 - 06/2002
3	Osteoporotic Fractures 11/2020 - 10/2011
3	Postmenopausal Osteoporosis 01/2019 - 05/2010
2	Hypertension (High Blood Pressure) 05/2019 - 02/2014
2	Metabolic Bone Diseases (Osteopenia) 05/2014 - 03/2012
2	Osteoarthritis 02/2014 - 01/2013
2	Hypercalcemia (Milk Alkali Syndrome) 06/2011 - 09/2005
2	Endometriosis 12/2009 - 03/2009
2	Prostatic Neoplasms (Prostate Cancer) 08/2008 - 08/2004
1	Hypercholesterolemia 01/2023
1	Muscular Atrophy (Muscle Atrophy) 01/2023
1	Sarcopenia 01/2023
1	Diabetes Mellitus 05/2019
1	Congenital Abnormalities (Deformity) 07/2014
1	Mental Disorders (Mental Disorder) 05/2014
1	Kidney Diseases (Kidney Disease) 05/2014
1	Hypoparathyroidism 05/2014
1	Breast Neoplasms (Breast Cancer) 06/2012
1	Wrist Fractures 10/2011
1	Bone Fractures (Bone Fracture) 06/2011
1	Pain (Aches) 03/2009
1	Neoplasms (Cancer) 08/2008
1	Hemorrhage 08/2008
1	Knee Osteoarthritis 04/2007
1	Urinary Calculi (Urinary Calculus) 11/2004
1	Neoplasm Metastasis (Metastasis) 08/2004
1	Osteosclerosis 08/2004

Drug/Important Bio-Agent (IBA)

6	Teriparatide (Parathar)FDA Link 01/2017 - 09/2012
5	alfacalcidolIBA 11/2021 - 06/2011
5	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2021 - 01/2004
5	YM 529IBA 11/2020 - 01/2009
5	MineralsIBA 05/2013 - 11/2004
4	Diphosphonates (Bisphosphonates)IBA 01/2023 - 11/2004
4	AcidsIBA 01/2023 - 01/2009
4	Risedronic Acid (Actonel)FDA LinkGeneric 07/2017 - 01/2004
4	eldecalcitol (ED 71)IBA 07/2013 - 09/2005
3	Raloxifene Hydrochloride (Evista)FDA Link 01/2023 - 05/2019
3	Vitamin K 2 (Vitamin K2)IBA 07/2017 - 04/2004
3	Vitamin D FDA LinkGeneric 02/2014 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 01/2013 - 01/2005
2	25-hydroxyvitamin DIBA 05/2019 - 02/2014
2	Denosumab FDA Link 12/2017 - 07/2014
2	hydroxide ionIBA 02/2014 - 06/2011
2	collagen type I trimeric cross-linked peptideIBA 11/2013 - 01/2006
2	dienogest FDA Link 12/2009 - 03/2009
1	NitrogenIBA 01/2023
1	Ki26894IBA 01/2023
1	CholesterolIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2023
1	Bone Density Conservation AgentsIBA 01/2023
1	elcatoninIBA 01/2019
1	RANK LigandIBA 12/2017
1	Monoclonal AntibodiesIBA 12/2017
1	Warfarin (Coumadin)FDA LinkGeneric 05/2014
1	CollagenIBA 11/2013
1	Indicators and Reagents (Reagents)IBA 11/2013
1	Parathyroid Hormone (Parathormone)IBA 09/2012
1	Zoledronic Acid (Zometa)FDA Link 06/2012
1	Hormones (Hormone)IBA 06/2012
1	Letrozole (Femara)FDA LinkGeneric 06/2012
1	SuspensionsIBA 03/2012
1	Cholecalciferol (Vitamin D3)FDA Link 10/2011
1	Buserelin (Suprefact)IBA 03/2009
1	Contrast MediaIBA 08/2008
1	P 536IBA 08/2008
1	GelatinIBA 04/2007
1	HydrogelsIBA 04/2007
1	Alkaline PhosphataseIBA 01/2006
1	Collagen Type I (Type I Collagen)IBA 01/2006
1	CalciumIBA 09/2005
1	Vitamin K FDA Link 09/2005
1	IsoflavonesIBA 09/2005
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2005
1	GlucocorticoidsIBA 01/2005
1	Therapeutic UsesIBA 01/2005
1	Pamidronate (Aredia)FDA LinkGeneric 11/2004
1	Etidronic Acid (HEDP)FDA LinkGeneric 01/2004
1	deoxypyridinolineIBA 01/2004
1	OsteocalcinIBA 06/2002

Therapy/Procedure

7	Therapeutics 01/2023 - 11/2003
1	Oral Administration 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 11/2019
1	Contraindications 05/2014
1	Injections 03/2013
1	Replacement Arthroplasty 01/2013
1	Drug Therapy (Chemotherapy) 08/2008
1	Osteotomy 04/2007
1	Bed Rest (Bedrest) 11/2004
1	Synchrotrons 08/2004